Organ-on-a-chip maker Emulate has launched an upgraded offering for researchers studying inflammatory bowel disease with its tissue model that helps illustrate how immune cells are activated and ...

Emulate is the leading provider of next generation in vitro biological models. Researchers use their organ-on-a-chip technology to understand and predict drug response with greater precision and ...

Emulate, Inc., the world leader in Organ-on-a-Chip technology, today announced the commercial launch of the AVA™ Emulation System , a self-contained instrument that cultures, incubates, and images up ...

Who will come up with the killer app for drug discovery, the thing that will make finding new medicines faster, cheaper, and less risky? No one has come close to figuring that out, but a group of ...

Emulate has raised $82 million in a series E round to help further develop and commercialize its organ-on-a-chip technology. The Boston, MA company has raised a total of $225 million since it was ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond ...

BOSTON--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today announced its new colon immune cell recruitment application, enabling the most human-relevant ...

Emulate, Inc., a leading provider of next-generation in vitro models, today announced that the Brain-Chip is being sent to the International Space Station U.S. National Laboratory (ISS National Lab) ...

Emulate, Inc., the leading provider of next-generation in vitro Organ-Chip models, today announced the release of its new Chip-R1™ Rigid Chip, designed to minimize drug absorption and enhance ...

BOSTON, April 15, 2025--(BUSINESS WIRE)--Emulate, Inc., a leading provider of next-generation in vitro models, today welcomed the U.S. Food and Drug Administration’s (FDA) newly announced plan to ...